CORC

在结果中检索

CORC

浏览/检索结果: 共18条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Sofosbuvir plus ribavirin with or without peginterferon for the treatment of hepatitis C virus: Results from a phase 3b study in China 期刊论文
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 卷号: 33, 期号: 6
作者:  Wei, Lai;  Xie, Qing;  Hou, Jin Lin;  Jia, Jidong;  Li, Wu
收藏  |  浏览/下载：33/0  |  提交时间：2019/12/04
Ledipasvir/sofosbuvir for treatment-naive and treatment-experienced Chinese patients with genotype 1 HCV: an open-label, phase 3b study 期刊论文
HEPATOLOGY INTERNATIONAL, 2018, 卷号: 12, 期号: 2
作者:  Zhang, Fangqiu;  Wei, Lai;  Xie, Qing;  Hou, Jin Lin;  Tang, Hong
收藏  |  浏览/下载：17/0  |  提交时间：2019/12/05
Safety and Efficacy of Sofosbuvir/Velpatasvir in Genotype 1-6 HCV-Infected Patients in China: Results from a Phase 3 Clinical Trial 期刊论文
HEPATOLOGY, 2018, 卷号: 68
作者:  Su, Minghua;  Duan, Zhongping;  Hou, Jinlin;  Jia, Jidong;  Dou, Xiaoguang
收藏  |  浏览/下载：31/0  |  提交时间：2019/12/05
Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China 期刊论文
HEPATOLOGY, 2018, 卷号: 68
作者:  Wei, Lai;  Xu, Xiaoyun;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Jifang
收藏  |  浏览/下载：21/0  |  提交时间：2019/12/05
Sofosbuvir plus ribavirin with or without peginterferon for the treatment of hepatitis C virus: Results from a phase 3b study in China 期刊论文
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 卷号: 33, 期号: 6
作者:  Wei, Lai;  Xie, Qing;  Hou, Jin Lin;  Jia, Jidong;  Li, Wu
收藏  |  浏览/下载：13/0  |  提交时间：2019/12/05
Safety and Efficacy of Coblopasvir and Sofosbuvir in Genotype 1, 2, 3, and 6 HCV-Infected Patients with Compensated Cirrhosis or without Cirrhosis 期刊论文
HEPATOLOGY, 2018, 卷号: 68
作者:  Jia, Jidong;  Rao, Huiying;  Song, Guangjun;  Li, Guangming;  Yang, Yongfeng
收藏  |  浏览/下载：16/0  |  提交时间：2019/12/05
Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China 会议论文
作者:  Wei, Lai;  Xu, Xiaoyun;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Jifang
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05
Quantitative assessment of liver fibrosis (qFibrosis) reveals precise outcomes in Ishak "stable" patients on anti-HBV therapy 期刊论文
SCIENTIFIC REPORTS, 2018, 卷号: 8
作者:  Sun, Yameng;  Zhou, Jialing;  Wu, Xiaoning;  Chen, Yongpeng;  Piao, Hongxin
收藏  |  浏览/下载：13/0  |  提交时间：2019/12/05
On-treatment changes of liver stiffness at week 26 could predict 2-year clinical outcomes in HBV-related compensated cirrhosis 期刊论文
LIVER INTERNATIONAL, 2018, 卷号: 38, 期号: 6
作者:  Wu, Shanshan;  Kong, Yuanyuan;  Piao, Hongxin;  Jiang, Wei;  Xie, Wen
收藏  |  浏览/下载：18/0  |  提交时间：2019/12/05
Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China 会议论文
作者:  Wei, Lai;  Xu, Xiaoyun;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Jifang
收藏  |  浏览/下载：11/0  |  提交时间：2019/11/19

©版权所有 ©2017 CSpace - Powered by CSpace